InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,585.71
(
-0.71%
)
US TECH 100
18,860.80
(
-1.10%
)
Dow Jones
41,027.80
(
-0.54%
)
Brent Oil
77.96
(
-1.31%
)
Bitcoin
59,050.79
(
-0.75%
)
Post# of 27603
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Katfish

Send PM Follow Ignore
Followers 80
Posts 24680
Boards Moderated 1
Alias Born 09/08/2000

Katfish

Member Level

Re: None

Friday, 04/05/2024 7:50:59 AM

Friday, April 05, 2024 7:50:59 AM

Post# of 27603
CADL - 6.40 Pre-market at 8.07/8.09

Candel Therapeutics shares are trading higher on continued strength after the company on Thursday announced interim data from the randomized phase 2 clinical trial of CAN-2409 in non-metastatic prostate cancer.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up